Management of cerebral venous thrombosis due to adenoviral COVID‐19 vaccination

A Scutelnic, K Krzywicka, J Mbroh… - Annals of …, 2022 - Wiley Online Library
Objective Cerebral venous thrombosis (CVT) caused by vaccine‐induced immune
thrombotic thrombocytopenia (VITT) is a rare adverse effect of adenovirus‐based severe
acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) vaccines. In March 2021, after
autoimmune pathogenesis of VITT was discovered, treatment recommendations were
developed. These comprised immunomodulation, non‐heparin anticoagulants, and
avoidance of platelet transfusion. The aim of this study was to evaluate adherence to these …

[PDF][PDF] Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 Vaccination

J Mbroh, A van de Munckhof, S Mayte, DA de Sousa… - 2022 - helda.helsinki.fi
Objective: Cerebral venous thrombosis (CVT) caused by vaccine-induced immune
thrombotic thrombocytopenia (VITT) is a rare adverse effect of adenovirus-based severe
acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) vaccines. In March 2021, after
autoimmune pathogenesis of VITT was discovered, treatment recommendations were
developed. These comprised immunomodulation, non-heparin anticoagulants, and
avoidance of platelet transfusion. The aim of this study was to evaluate adherence to these …
以上显示的是最相近的搜索结果。 查看全部搜索结果